US Tech 100

19,804.00

0.64%

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

OPGN

OpGen (OPGN)

OpGen Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:OPGN

<< Previous 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Next >>

Date	Time	Source	Headline	Symbol	Company
04/15/2019	4:26PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPGN	OpGen Inc
04/01/2019	2:54PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OPGN	OpGen Inc
03/29/2019	9:04AM	GlobeNewswire Inc.	OpGen Announces Closing of Public Offering of Common Stock	NASDAQ:OPGN	OpGen Inc
03/28/2019	7:30AM	GlobeNewswire Inc.	OpGen Data Predicting Antibiotic Resistance Published in Antimicrobial Agents and Chemotherapy Journal	NASDAQ:OPGN	OpGen Inc
03/27/2019	3:28PM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:OPGN	OpGen Inc
03/26/2019	5:19PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPGN	OpGen Inc
03/26/2019	5:11PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:OPGN	OpGen Inc
03/26/2019	9:00AM	GlobeNewswire Inc.	OpGen Announces Pricing of a $5.4 Million Public Offering of Common Stock	NASDAQ:OPGN	OpGen Inc
03/26/2019	6:02AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:OPGN	OpGen Inc
03/25/2019	7:30AM	GlobeNewswire Inc.	OpGen and Merck’s ILÚM Health Solutions to Host Event at VIII International Symposium on Hospital Acquired Infections and ...	NASDAQ:OPGN	OpGen Inc
03/22/2019	6:02AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:OPGN	OpGen Inc
03/22/2019	6:01AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:OPGN	OpGen Inc
03/15/2019	4:18PM	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:OPGN	OpGen Inc
03/15/2019	4:14PM	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:OPGN	OpGen Inc
03/13/2019	5:25PM	Edgar (US Regulatory)	Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)	NASDAQ:OPGN	OpGen Inc
03/13/2019	4:36PM	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:OPGN	OpGen Inc
03/01/2019	5:33PM	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:OPGN	OpGen Inc
02/28/2019	4:52PM	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:OPGN	OpGen Inc
02/27/2019	4:45PM	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:OPGN	OpGen Inc
02/26/2019	5:25PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPGN	OpGen Inc
02/26/2019	4:02PM	GlobeNewswire Inc.	OpGen Reports Fourth Quarter and 2018 Financial Results and Provides Business Update	NASDAQ:OPGN	OpGen Inc
02/25/2019	4:25PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:OPGN	OpGen Inc
02/25/2019	4:22PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPGN	OpGen Inc
02/25/2019	8:30AM	GlobeNewswire Inc.	OpGen Appoints R. Don Elsey to Board of Directors	NASDAQ:OPGN	OpGen Inc
02/20/2019	9:00AM	GlobeNewswire Inc.	OpGen Announces Date of Fourth Quarter and Fiscal Year 2018 Financial Results Conference Call	NASDAQ:OPGN	OpGen Inc
02/14/2019	2:44PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:OPGN	OpGen Inc
02/14/2019	11:13AM	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:OPGN	OpGen Inc
02/05/2019	7:30AM	GlobeNewswire Inc.	OpGen Completes Clinical Trials for its Initial FDA 510(k) Submission	NASDAQ:OPGN	OpGen Inc
01/15/2019	10:55AM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:OPGN	OpGen Inc
01/03/2019	3:44PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:OPGN	OpGen Inc